AGITATED SOLUTIONS, INC. — SEC Form D Filing

AGITATED SOLUTIONS, INC. filed an SEC Form D on October 20, 2026, reporting $6.39M raised in Other Health Care.

Form D filing details

Filing
SEC Form D
Filing date
October 20, 2026
Amount reported
$6.39M
Round stage
Series A driven by a $6.38M equity round to advance clinical development and commercialization following initial grant funding.
Industry
Other Health Care
Website
https://agitatedsolutions.com

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Manual preparation of agitated saline contrast for echocardiograms is inconsistent, labor-intensive, and introduces clinical variability into cardiac diagnostic imaging.

Solution

AGITATED SOLUTIONS develops automated fluid agitation and microbubble delivery systems that standardize contrast generation for enhanced diagnostic ultrasound imaging.

Why now

Increasing reliance on point-of-care ultrasound and non-invasive cardiac diagnostics necessitates standardized, operator-independent contrast agent preparation.

Source: SEC EDGAR Form D filing